Company Filing History:
2 out of 1,119 
2 out of 192 
2 out of 8,686 
Years Active: 2024
Title: Innovations by Nadean M Gutierrez: Pioneering Antiviral Solutions
Introduction
Nadean M Gutierrez, a talented inventor based in Devine, Texas, has made significant contributions to the field of antiviral treatments. With a total of two patents to her name, her innovative work focuses on addressing urgent health challenges posed by various coronaviruses, including the SARS-CoV-1 and SARS-CoV-2 strains.
Latest Patents
Nadean's latest patents showcase her commitment to developing crucial antiviral solutions. The first patent is for inhibitors designed for coronavirus, targeting not just SARS-CoV-1 and SARS-CoV-2 (Covid-19), but also MERS-CoV and their variants. This invention includes methods for treating subjects suffering from these respiratory diseases. Her second patent involves antiviral drugs specifically targeting the N-terminal domain (NTD) of the spike receptor binding domain (RBD) of the coronavirus, along with methods for treating individuals affected by the virus.
Career Highlights
Throughout her career, Nadean has collaborated with reputable organizations, such as the Southwest Research Institute and the Henry M. Jackson Foundation for the Advancement of Military Medicine Inc. Her work has had a significant impact in the realm of medical research and development, particularly in the fight against viral diseases.
Collaborations
Nadean has had the privilege of working alongside notable colleagues, including Jonathan A Bohmann and Joseph A McDonough. Their collaborative efforts have undoubtedly enriched her research and innovations, contributing to the advancement of antiviral therapies.
Conclusion
In summary, Nadean M Gutierrez stands out as a remarkable inventor whose work in the field of antiviral medications is making a meaningful difference in healthcare. Her innovative patents not only highlight her expertise but also serve as a beacon of hope for individuals affected by respiratory diseases caused by coronaviruses. As she continues to explore new frontiers in medical innovation, her contributions will surely inspire future advancements in this critical field.